Gland Pharma Limited (GLAND) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE068V01023
Key metrics
- Market Cap
- ₹47,428 Cr
- P/E Ratio
- 42.04
- EPS
- 68.39
- Book Value
- 628.68
- P/B Ratio
- 4.59
- ROE
- 9.92%
- ROCE
- 11.34%
- Debt / Equity
- 0.03
- Net Margin
- 16.04%
- Revenue Growth
- 14.67%
- Profit Growth
- 47.07%
- Dividend Yield
- 0.69%
- 52W High
- ₹3,039.80
- 52W Low
- ₹1,573.60
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Gland Pharma Limited
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, and neurological and central nervous system; blood related, ophthalmics and otologicals, cardiac, gastro-intestinal, and hormonal products; pain, neuromuscular blocking agents, and analgesics; respiratory and pulmonology; and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier preparation, and technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
- Headquarters
- Hyderabad, India
- Employees
- 4,332
- Promoter Holding
- 51.77%
The full Gland Pharma Limited analysis
Create a free account to open the complete GLAND deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.